MX365437B - Metodo para seleccionar una linea celular permisiva para replicar virus aviares. - Google Patents
Metodo para seleccionar una linea celular permisiva para replicar virus aviares.Info
- Publication number
- MX365437B MX365437B MX2016001041A MX2016001041A MX365437B MX 365437 B MX365437 B MX 365437B MX 2016001041 A MX2016001041 A MX 2016001041A MX 2016001041 A MX2016001041 A MX 2016001041A MX 365437 B MX365437 B MX 365437B
- Authority
- MX
- Mexico
- Prior art keywords
- cell line
- culturing
- days
- avian
- selecting
- Prior art date
Links
- 241000271566 Aves Species 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title 1
- 230000003362 replicative effect Effects 0.000 title 1
- 238000012258 culturing Methods 0.000 abstract 5
- 210000004027 cell Anatomy 0.000 abstract 3
- 210000002966 serum Anatomy 0.000 abstract 3
- 230000029812 viral genome replication Effects 0.000 abstract 2
- 210000001671 embryonic stem cell Anatomy 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0629—Keratinocytes; Whole skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16351—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16351—Methods of production or purification of viral material
- C12N2710/16352—Methods of production or purification of viral material relating to complementin g cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10051—Methods of production or purification of viral material
- C12N2720/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención se refiere a un método para obtener una línea de células aviares no transformadas que permite la replicación de virus aviares in vitro, que comprende por lo menos los siguientes pasos: a) cultivar células madre embrionarias aviares en presencia de un estroma durante por lo menos 3 días; b) cultivar durante por lo menos 2 días en un medio con una concentración baja de suero; c) cultivar durante por lo menos 2 días en un medio de concentración baja de suero que comprende entre 1 y 10 mM de hexametilen bisacetamida (HMBA); d) cultivar durante por lo menos 10 días en un medio de concentración baja de suero; y e) cultivar o congelar una línea celular aviar permitiendo la replicación de virus aviares; la invención también se refiere a la línea celular resultante y al uso de la misma en preparaciones vacunales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1357346A FR3008992A1 (fr) | 2013-07-25 | 2013-07-25 | Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires |
PCT/EP2014/065946 WO2015011238A1 (fr) | 2013-07-25 | 2014-07-24 | Procede de sélection d'une lignee cellulaire permissive pour la replication de virus aviaires |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016001041A MX2016001041A (es) | 2016-08-12 |
MX365437B true MX365437B (es) | 2019-06-03 |
Family
ID=49876756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016001041A MX365437B (es) | 2013-07-25 | 2014-07-24 | Metodo para seleccionar una linea celular permisiva para replicar virus aviares. |
Country Status (11)
Country | Link |
---|---|
US (1) | US10053672B2 (es) |
EP (1) | EP3024927B1 (es) |
CN (1) | CN105408471B (es) |
AU (1) | AU2014295022B2 (es) |
BR (1) | BR112016001462A2 (es) |
CA (1) | CA2918845C (es) |
ES (1) | ES2662344T3 (es) |
FR (1) | FR3008992A1 (es) |
MX (1) | MX365437B (es) |
NZ (1) | NZ716434A (es) |
WO (1) | WO2015011238A1 (es) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0775746T3 (da) | 1995-07-03 | 2006-04-03 | Akzo Nobel Nv | Vaccine mod fjerkræcoccidiose |
US5827738A (en) * | 1995-10-27 | 1998-10-27 | Board Of Trustees Operating Michigan State University | Sustainable chick cell line infected with Marek's disease virus |
US5672485A (en) | 1996-08-13 | 1997-09-30 | Regents Of The University Of Minnesota | Immortalized cell lines for virus growth |
FR2836924B1 (fr) * | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
FR2898909A1 (fr) | 2006-03-24 | 2007-09-28 | Agronomique Inst Nat Rech | Combinaison de marqueurs de cellules aviaires |
FR2898908A1 (fr) * | 2006-03-24 | 2007-09-28 | Agronomique Inst Nat Rech | Procede de preparation de cellules aviaires differenciees et genes impliques dans le maintien de la pluripotence |
EP1985305A1 (en) * | 2007-04-24 | 2008-10-29 | Vivalis | Duck embryonic derived stem cell lines for the production of viral vaccines |
CN103157107A (zh) * | 2011-12-14 | 2013-06-19 | 普莱柯生物工程股份有限公司 | 用连续传代细胞系生产鸡马立克氏病疫苗及方法 |
-
2013
- 2013-07-25 FR FR1357346A patent/FR3008992A1/fr active Pending
-
2014
- 2014-07-24 CN CN201480041662.1A patent/CN105408471B/zh active Active
- 2014-07-24 EP EP14742242.2A patent/EP3024927B1/fr active Active
- 2014-07-24 WO PCT/EP2014/065946 patent/WO2015011238A1/fr active Application Filing
- 2014-07-24 MX MX2016001041A patent/MX365437B/es active IP Right Grant
- 2014-07-24 CA CA2918845A patent/CA2918845C/fr active Active
- 2014-07-24 ES ES14742242.2T patent/ES2662344T3/es active Active
- 2014-07-24 BR BR112016001462A patent/BR112016001462A2/pt not_active Application Discontinuation
- 2014-07-24 NZ NZ716434A patent/NZ716434A/en unknown
- 2014-07-24 AU AU2014295022A patent/AU2014295022B2/en active Active
- 2014-07-24 US US14/905,485 patent/US10053672B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10053672B2 (en) | 2018-08-21 |
CA2918845C (fr) | 2021-11-02 |
NZ716434A (en) | 2022-01-28 |
BR112016001462A2 (pt) | 2017-08-29 |
EP3024927B1 (fr) | 2017-12-27 |
ES2662344T3 (es) | 2018-04-06 |
AU2014295022A1 (en) | 2016-02-18 |
EP3024927A1 (fr) | 2016-06-01 |
AU2014295022B2 (en) | 2020-05-28 |
CA2918845A1 (fr) | 2015-01-29 |
CN105408471B (zh) | 2019-01-18 |
FR3008992A1 (fr) | 2015-01-30 |
MX2016001041A (es) | 2016-08-12 |
US20160152956A1 (en) | 2016-06-02 |
CN105408471A (zh) | 2016-03-16 |
WO2015011238A1 (fr) | 2015-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20210057T1 (hr) | Presađivanje stem stanica s kombinacijom sredstva koje cilja stem stanice i modulacija imunoregulatorne signalizacije | |
BR112017007770A2 (pt) | cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc. | |
EA201490050A1 (ru) | Композиции и способы повышения биоэнергетического состояния женских зародышевых клеток | |
CL2016003096A1 (es) | Métodos para cosechar cultivos de células de mamífero | |
WO2016070166A3 (en) | Messenger una molecules and uses thereof | |
ES2627330T3 (es) | Uso de JAZ5a para mejorar la resistencia a la sequía en una planta | |
MX2017007196A (es) | Fibroblastos de embrion de pollo inmortalizados. | |
MY192561A (en) | Taurine supplemented cell culture medium and methods of use | |
EA201391523A1 (ru) | Композиции и способы для переноса энергии митохондрий аутологичных герминативных клеток | |
AR069956A1 (es) | Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas | |
EA201690600A1 (ru) | Метаболически оптимизированная клеточная культура | |
WO2007048089A3 (en) | Multi-plasmid system for the production of influenza virus | |
BR112015021189A2 (pt) | métodos de banco de células de alta densidade | |
AR094389A1 (es) | USO DE INHIBIDORES DE iNOS PARA AUMENTAR EL RENDIMIENTO VÍRICO EN CULTIVOS | |
EA201591817A1 (ru) | Не содержащая сыворотки среда для культивирования клеток | |
BR112012025022A2 (pt) | "método de redução da fragmentação de dna em uma amostra de espermatozoides separados" | |
MX2018006373A (es) | Produccion de virus en cultivos celulares. | |
MX2017008410A (es) | Reduccion selectiva de residuos cisteina en anticuerpos il-17. | |
BR112014019328A8 (pt) | Perfil de fenótipo de células progenitoras retinais humanas | |
AR069885A1 (es) | Metodos para producir el virus de estomatitis vesicular (vsv) atenuado en un cultivo celular y para mejorar el empaque del vsv de propagacion defectuosa, composicion inmunogenica, celula aislada y secuencia de control transcripcional | |
MX2022008298A (es) | Anticuerpo para sesgar proporciones de sexos y metodos de uso del mismo. | |
NZ716434A (en) | Method for selecting a permissive cell line for replicating avian viruses | |
BR112018015527A2 (pt) | métodos para produção de vírus | |
MX2015010887A (es) | Formulaciones y metodos para aumentar la produccion de proteinas recombinantes. | |
BR112017007213A2 (pt) | "processamento e utilização de fluidos do trato reprodutivo para melhorar a produção in vitro de embriões de mamífero" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |